Skip to content

Advertisement

  • Research
  • Open Access

Sesamin ameliorates oxidative stress and mortality in kainic acid-induced status epilepticus by inhibition of MAPK and COX-2 activation

  • 1, 2Email author,
  • 3Email author,
  • 3,
  • 3,
  • 3,
  • 1,
  • 1,
  • 1,
  • 1 and
  • †4, 5
†Contributed equally
Journal of Neuroinflammation20118:57

https://doi.org/10.1186/1742-2094-8-57

©  Hsieh et al; licensee BioMed Central Ltd. 2011

  • Received: 14 December 2010
  • Accepted: 24 May 2011
  • Published:

Abstract

Background

Kainic acid (KA)-induced status epilepticus (SE) was involved with release of free radicals. Sesamin is a well-known antioxidant from sesame seeds and it scavenges free radicals in several brain injury models. However the neuroprotective mechanism of sesamin to KA-induced seizure has not been studied.

Methods

Rodents (male FVB mice and Sprague-Dawley rats) were fed with sesamin extract (90% of sesamin and 10% sesamolin), 15 mg/kg or 30 mg/kg, for 3 days before KA subcutaneous injection. The effect of sesamin on KA-induced cell injury was also investigated on several cellular pathways including neuronal plasticity (RhoA), neurodegeneration (Caspase-3), and inflammation (COX-2) in PC12 cells and microglial BV-2 cells.

Results

Treatment with sesamin extract (30 mg/kg) significantly increased plasma α-tocopherol level 50% and 55.8% from rats without and with KA treatment, respectively. It also decreased malondialdehyde (MDA) from 145% to 117% (p = 0.017) and preserved superoxide dismutase from 55% of the vehicle control mice to 81% of sesamin-treated mice, respectively to the normal levels (p = 0.013). The treatment significantly decreased the mortality from 22% to 0% in rats. Sesamin was effective to protect PC12 cells and BV-2 cells from KA-injury in a dose-dependent manner. It decreased the release of Ca2+, reactive oxygen species, and MDA from PC12 cells. Western blot analysis revealed that sesamin significantly reduced ERK1/2, p38 mitogen-activated protein kinases, Caspase-3, and COX-2 expression in both cells and RhoA expression in BV-2 cells. Furthermore, Sesamin was able to reduce PGE2 production from both cells under KA-stimulation.

Conclusions

Taken together, it suggests that sesamin could protect KA-induced brain injury through anti-inflammatory and partially antioxidative mechanisms.

Keywords

  • Status epilepticus
  • PC12 cells
  • BV-2 cells
  • sesamin
  • kainic acid
  • reactive oxygen species
  • thiobarbituric acid reactive substances
  • nitric acid
  • superoxide dismutase
  • mitogen-activated protein kinases
  • COX-2

Background

Status epilepticus (SE) is defined as a period of continuous seizure activity [1, 2]. Prolonged febrile seizures and SE have been implicated as a major predisposing factor for the development of mesial temporal sclerosis and temporal lobe epilepsy [1, 3]. This emergency condition requires a prompt and appropriate treatment to prevent brain damage and eventual death. In animal models, similar pathologic changes can be observed with electrically and chemically induced seizures [4–7]. Animal studies show that SE causes recurrent spontaneous seizures (epilepsy) [6, 8, 9] and releases free radicals from experimental models of kainic acid (KA), pilocarpine, pentylenetetrazole, and ferric chloride [10–14].

KA, a glutamate related chemical, induces neuronal excitability, reactive oxygen species (ROS) production and lipid peroxidation in neurons [15–17]. It triggers neuronal membrane depolarization by the release of calcium ions which are involved in nerve impulse transmission as the calcium action potential reaches the synapse [15]. The apoptosis of nerve cells can be triggered by a large number of intracellular calcium influx [18]. Mitogen-activated protein kinases (MAPKs) and Rho kinases are also associated with seizures, inflammation and apoptosis [19–21].

Sesamin and sesamolin are the major lignans from sesame seeds. Previously, we and others report that sesamin can protect against hypoxia-, H2 O2 -or 1-methyl-4-phenyl-pyridine (MPP+)-induced brain and PC12 cells injuries [22, 23]. Various plant antioxidants have been shown to protect brain form KA-induced calcium ions and ROS [24–26]. Sesamin also inhibits nitric oxide (NO) and cytokine production in lipopolysaccharide (LPS)-and oxidative-stressed BV-2 microglia [27, 28].

It is perceivable that sesamin could protect animal from KA-induced SE as in other brain injury models. Therefore, this study investigated the effect of sesamin on the KA-induced SE animals as well as the protective mechanism in neuronal PC12 cells and microglial BV-2 cells.

Methods

Reagents

Pure sesamin and sesamin extract (90% sesamin and 10% sesamolin, as determined by HPLC) were purchased from Joben Bio-medical co. (Kaohsiung, Taiwan). Kainic acid (KA) was obtained from Sigma-Aldrich (Steinheim, Germany) and Cayman Chemical (Ann Arbor, MI, USA), 2', 7'-dichlorodihydrofluorescein diacetate (H2 DCF-DA) was obtained from Molecular Probes (Eugene, OR, USA).

Oxidative Stress in mice

Adult male FVB mice, 23-25 g of weight, were used for the study. SE was induced with KA (30 mg/ml in phosphate-buffered saline (PBS), 30 mg/kg, s.c.). Sesamin extract was diluted with corn oil (30 mg/ml). The animals were fed with 2 different dosages of sesamin extract (15 mg/kg or 30 mg/kg) by gavage for 3 days before the KA experiment. The vehicle control group was fed with equal volume of corn oil. The procedures were approved by the Institutional Animal Care and Use Committee, Taichung Veterans General Hospital (IACUC Approval No. LA-97490) and all possible steps were taken to avoid animals' suffering at each stage of experiments.

Diazepam at lethal dosage, 60 mg/kg i.p., was given to stop seizures 2 h after KA injection and the animal was sacrificed by decapitation under CO2 asphyxia. The naïve animal serves as a control. The whole brain was removed and immediately frozen in liquid nitrogen and stored at-70°C until use.

Malondialdehyde (MDA) as a part of thiobarbituric acid reacting substances (TBARS) was used as an indicator of lipid peroxidation. To estimate oxidative stress, the amount of TBARS in the brain from each group was measured. Manual homogenization of brains was carried out at 4°C with a cold buffer. Protein concentration of the homogenate was determined by BCA protein assay using bovine serum albumin as a standard. The detection of TBARS was from the modified method of Ohkawa [29]. Briefly, the sample (0.2 ml) was mixed with the same volume of 20% (w/v) trichloroacetic acid and 1% (w/v) thiobarbituric acid in 0.3% (w/v) NaOH. The mixture was heated in the water bath at 95°C for 40 min, cooled to room temperature and centrifugation at 5000 rpm for 5 min at 4°C. The fluorescence of the supernatant was determined by a spectrophotometer with excitation at 544 nm and emission at 590 nm.

Superoxide dismutase (SOD) activity was determined by a RANSOD kit (Randox, USA). This method was based on the formation of red formazan from the reaction of 2-(4-iodophenyl)-3-(4-nitrophenol)-5-phenyltetrazolium chloride and superoxide radical and assayed in a spectrophotometer at 505 nm. The inhibition of the produced chromogen was proportional to the activity of the SOD present in the sample. A 50% inhibition was defined as one unit of SOD, and specific activity was expressed as units per milligram protein.

Measurement of tocopherols

Plasma α-tocopherol was determined by HPLC method. Briefly, plasma was treated with anti-oxidant reagent (0.25% BHT and 0.2% vitamin C in methanol, 1:7), mixed and centrifuged for 10 min × 12000 g. Sample (20 μl) or internal control was then injected to HPLC system (BAS PM-80) with C18 column (4.6 × 150 mm, 5 μm; mobile phase, 95% methanol, flow rate: 1.0 ml/min) and fluorescence detector with 296 nm excitation, and 340 nm emission.

Mortality and behavior

Adult male Sprague-Dawley rats weighing 380-420 g were used to study the protective effect of sesamin extract. Rats were fed with sesamin extract (30 mg/kg/day) for 3 days before the SE experiment. The control group was treated with the vehicle corn oil. SE was induced with kainic acid (12 mg/kg, in PBS, s.c.). Each behavioral seizure was recorded according to a modified classification from Racine [30]: 0, immobility or exploring; 1, facial clonus; 2, head nodding; 3, unilateral forelimb clonus; 4, bilateral forelimb clonus and rearing; 5, falling; 6, repeated falling; 7, bouncing; 8, generalized tonus. Four behavioral patterns of SE could be recognized: immobile (class 0), exploratory (class 0), masticatory (class 1-2) and clonic (class 3-8) [31]. Diazepam, 25 mg/kg i.p., was given to stop seizures at 5 h of SE and the 10-h mortality rate was recorded.

Cell culture

Rat pheochromacytoma (PC12) cells and murine microglial BV-2 cells were maintained in Dulbecco's modified Eagle's medium (DMEM) supplemented with 10% fetal bovine serum (FBS), 5% heat-inactivated horse serum, 100 U/ml penicillin and 100 μg/ml streptomycin at 37°C in a humidified incubator under 5% CO2. Confluent cultures were passaged by trypsinization. For experiments, cells were washed twice with warm DMEM (without phenol red), then treated in serum-free medium. In all experiments, cells were treated with and without sesamin and/or KA-stress for the indicated times.

Cell viability

Cell viability was measured with blue formazan that was metabolized from colorless 3-(4,5-dimethyl-thiazol-2-yl)-2,5-diphenyl tetrazolium bromide (MTT) by mitochondrial dehydrogenases, which are active only in live cells. PC12 cells were pre-incubated in 24-well plates at a density of 5 × 105 cells per well for 24 h, and then washed with PBS. Cells with various concentrations of sesamin were treated with 150 mM KA for 24 h, and grown in 0.5 mg/ml MTT at 37°C. One hour later, 200 μl of solubilization solution was added to each well and absorption values read at 540 nm on an automated spectraMAX 340 (Molecular Devices, Sunnyvale, CA, USA) microtiter plate reader. Data were expressed as the mean percent of viable cells vs. control.

Lactate dehydrogenase (LDH) release assay

Cytotoxicity was determined by measuring the release of LDH. PC12 cells or BV-2 cells with various concentrations of sesamin were treated with 150 mM KA for 24 h and the supernatant was used to assay LDH activity. The reaction was initiated by mixing 0.1 ml of cell-free supernatant with potassium phosphate buffer containing nicotinamide adenine dinucleotide (NADH) and sodium pyruvate in a final volume of 0.2 ml to 96-well plate. The rate of absorbance was read at 490/630 nm on a spectraMAX 340 instrument. Data were expressed as the mean percent of viable cells vs. 150 mM KA control.

Calcium release

PC12 cells or BV-2 cells with various concentrations of sesamin were treated with 150 mM KA for 24 h and the supernatant was used to assay the release of Ca2+. The 10 μl supernatant was added to 1 ml Ca2+ reagent (Diagnostic Systems, Holzheim, Germany) and mixed well, stood for 5 min, then transferred the 100 μl aliquot to 96 well. The calcium concentration was determined using a microplate reader with a 620 nm absorbance and quantified with a 10 mg/ml Ca2+ standard solution.

Reactive oxygen species generation

Intracellular accumulation of ROS was determined with H2 DCF-DA. This nonfluorescent compound accumulates within cells upon deacetylation. H2 DCF then reacts with ROS to form fluorescent dichlorofluorescein (DCF). PC12 cells or BV-2 cells were plated in 96-well plates and grown for 24 h before addition of DMEM plus 10 μM H2 DCF-DA, incubation for 60 min at 37°C, and treatment with 150 μM KA for 60 or 120 min. Cells were then washed twice with room temperature Hank's balanced salt solution (HBSS without phenol red). Cellular fluorescence was monitored on a Fluoroskan Ascent fluorometer (Labsystems Oy, Helsinki, Finland) using an excitation wavelength of 485 nm and emission wavelength of 538 nm.

Measurement of lipid peroxidation

Lipid peroxidation is quantified by measuring malondialdehyde (MDA) of PC12 cells by lipid peroxidation (LPO) assay kit (Cayman Chemical, Ann Arbor, MI, USA). This kit works on the principle of condensation of one molecule of either MDA or 4-hydroxyalkenals with two molecules of N-methyl-2-phenylindole to yield a stable chromophore. MDA levels were assayed by measuring the amount expressed in 5 × 105 cells and the absorbance at 500 nm was determined using an ELISA reader (spectraMAX 340).

Preparation of cell extracts

Test medium was removed from culture dishes and cells were washed twice with ice-cold PBS, scraped off with a rubber policeman, and centrifuged at 200 × g for 10 min at 4°C. The cell pellets were resuspended in an appropriate volume (~4 × 107 cells/ml) of lysis buffer containing 20 mM Tris-HCl, pH 7.5, 137 mM NaCl, 1 mM phenylmethylsulfonylfluoride, 10 μg/ml aprotinin, 10 μg/ml leupeptin, and 5 μg/ml pepstain A. The suspension was then sonicated. Protein concentration of samples was determined by Bradford assay (Bio-Rad, Hemel, Hempstead, UK) and samples equilibrated to 2 mg/ml with lysis buffer.

Western blotting

Protein samples from PC12 cells or BV-2 cells containing 50 μg of protein were separated on 12% sodium dodecyl sulfate-polyacrylamide gels and transferred to immobile polyvinylidene difluoride membranes (Millipore, Bedford, MA). Membranes were incubated for 1 h with 5% dry skim milk in TBST buffer (0.1 M Tris-HCl, pH 7.4, 0.9% NaCl, 0.1% Tween-20) to block nonspecific binding, and then incubated with rabbit anti-COX-2, Rho A (1:1000; Cayman chemical; Cell Signaling, USA), and anti-phospho-MAPKs. Subsequently, membranes were incubated with secondary antibody streptavidin-horseradish peroxidase conjugated affinity goat anti-rabbit IgG (Jackson, West Grove, PA, USA).

Statistical analysis

Data were expressed as the mean ± SD and mean ± SE, in vivo and in vitro experiments, respectively. For single variable comparisons, Student's test was used. For multiple variable comparisons, data were analyzed by one-way analysis of variance (ANOVA) followed by Scheffe's test or the least significant differences post-hoc test. Categorical variables were analyzed by use of Fisher's exact test, two-tailed Pearson's chi-square test. Kendall's tau-c was used for testing a trend. P values less than 0.05 were considered significant.

Results

In vivo effect of sesamin extract on the KA-induced oxidative stress

Treatment with sesamin extract (30 mg/kg) significantly increased 50% and 55.8% of plasma α-tocopherol levels from rats without and with KA treatment, compared to the baseline level, respectively. In contrast, the plasma α-tocopherol level did not change in vehicle control rats. The TBARS level of the vehicle control group was 145% of the naïve control animals. The TBARS level of the sesamin (S-30) group was 117% of the naïve control and significantly different from that of the vehicle control (V-30) (p = 0.017). The sesamin treatment in SE mice increased the SOD activity from 55% of the vehicle control mice to 81% of sesamin-treated mice, respectively to the normal levels. (p = 0.013). However at 15 mg/kg dosage of sesamin treatment, neither TBARS nor SOD activity was different from the vehicle control (V-15) (p > 0.05, Table 1).
Table 1

Effects of sesamin extract on TBARS (nmol/mg protein) and SOD (units/mg protein) in the mice with 2-h KA-induced SE

Variable

Vehicle

Sesamin extract

Naive

P-value a

P-value b

 

M ± SD

M ± SD

M ± SD

 

(V, S)

(V, N)

(S, N)

15 mg/kg

       

   TBARS

0.96 ± 0.22

0.85 ± 0.10

0.57 ± 0.04

0.001**

0.225

0.0002**

0.004**

   SOD

4.18 ± 1.01

5.27 ± 2.01

8.79 ± 1.22

0.005**

0.686

0.003**

0.006**

30 mg/kg

       

   TBARS

0.86 ± 0.14

0.69 ± 0.14

0.59 ± 0.06

0.003**

0.017*

0.001**

0.126

   SOD

5.17 ± 1.90

7.54 ± 2.10

9.48 ± 1.17

0.0004**

0.013*

0.0001**

0.049*

M ± SD: mean ± standard deviation. N: naïve. S: sesamin extract. V: vehicle.

a One-way ANOVA test.

b Least significant differences post-hoc test. *P < 0.05, **P < 0.01.

Effect on mortality and behavior

Since the lower dosage of sesamin (15 mg/kg) did not have a good antioxidant effect, we used the higher dosage for the next experiment. The result showed that treatment with sesamin extract (30 mg/kg) on the rats with KA-induced SE decreased the mortality rate from 22% of the vehicle (V-30) group to 0% (p = 0.049). However, sesamin extract did not significantly attenuate the maximal seizure classes or the predominant behavioral seizure patterns as compared with the vehicle (p > 0.05, Tables 2 and 3). Nevertheless, there was a trend of decreasing the clonic pattern of SE by sesamin treatment that 8/23 (35%) in the vehicle (V-30) group dropped to 3/22 (14%) in the sesamin (S-30) group (Table 3).
Table 2

Effects of sesamin extract on the maximal seizure class (MSC) and mortality rate of the rats with 5-h KA-induced SE

Variables

Control

(V-30)

n (%)

Sesamin

(S-30)

n (%)

P-value

Mortality

5 (22)

0 (0)

0.049a

MSC

   

1-2

2 (9)

1 (4)

0.797b

3-6

17 (74)

16 (73)

0.530c

7-8

4 (17)

5 (23)

 

a Fisher's exact test.

b Pearson's chi-square test: all seizure classes were taken together.

c Kendall's tau-c: all seizure classes were taken together.

S-30: sesamin extract (30 mg/kg). V-30: vehicle.

Table 3

The effect of sesamin extract on the predominant behavior patterns of the rats with 5-h KA-induced SE

Behavior Pattern

Control

(V-30)

n (%)

Sesamin (S-30)

n (%)

P-value

Immobile or Exploratory

11 (48)

12 (54)

0.211a

Masticatory

4 (17)

7 (32)

0.323b

Clonic

8 (35)

3 (14)

 

a Pearson's chi-square test: all behavioral patterns were taken together.

b Kendall's tau-c: all behavioral patterns were taken together.

S-30: sesamin extract (30 mg/kg). V-30: vehicle.

In vitro protection of KA toxicity

KA can induce free radicals and damage neuronal cells, therefore the cell viability and LDH released from PC12 cells were measured using MTT and LDH ELISA assays [15]. As shown in Figure 1, PC12 cells were exposed to 150 μM KA for 24 h were protected by the presence of sesamin (0.1, 0.5, 1.0, or 2.0 μM). KA-induced LDH released was reduced and the cell viability was increased by sesamin treatment. Similarly, BV-2 cells were protected by sesamin under KA stimulation (data not shown).
Figure 1
Figure 1

Effect of sesamin on cell viability and cytotoxicity of kainic acid-stressed PC12 cells. Cells were treated with KA (150 μM) alone or with various concentrations (0.1, 0.5, 1.0, 2.0 μM) of sesamin for 24 h. (A) LDH release was decreased and (B) cell viability increased by sesamin. * P < 0.01 as compared to KA control.

KA-induced calcium release

KA triggers neurons membrane depolarization by the release of calcium ions [18]. Our result showed that KA induced calcium release from both PC12 and BV-2 cells in a time-dependent manner and sesamin reduced the calcium release more prominently from BV-2 cells than from PC12 cells (Figure 2).
Figure 2
Figure 2

Effect of sesamin on Ca 2+ generation from KA-treated PC12 cells and BV-2 cells. Cells were treated with KA (150 μM) alone or with various sesamin concentrations (0.1-2.0 μM) of sesamin for 24 h. Treatment with sesamin effectively reduced the release of Ca2+ under KA stress. * P < 0.01 as compared to the KA control.

KA-induced ROS and lipid peroxidation

KA-treated PC12 cells or BV-2 cells increased DCF fluorescence nearly one-fold after 120 min as compared with the control cells. Sesamin protected cells against KA-cytotoxicity by decreasing the ROS accumulation (DCF signals) in both cells (Figure 3). Marked increase in MDA level was observed in KA-exposed cells as compared with the control cells (Figures 4-5). Treatment with sesamin significantly reduced MDA levels as compared to the KA-treated control (p < 0.01,).
Figure 3
Figure 3

Effect of sesamin on ROS accumulation in PC12 cells and BV-2 cells under KA stress. Sesamin effectively reduced the ROS production from (PC12 cells induced by KA stress (150 μM) at 120-min. * P < 0.01 as compared to the KA control.

Figure 4
Figure 4

Effect of sesamin on lipid peroxidation of PC12 cells under KA stress. Lipid peroxidation (LPO) was determined by a LPO assay kit (Cayman Chemical, Ann Arbor, MI, USA). Malondialdehyde (MDA) of PC12 cells was induced by 24-h KA stress (150 μM) and effectively reduced by sesamin. * P < 0.01 as compared to the KA control.

Figure 5
Figure 5

Kainic acid-induced nitrite production. BV-2 cells were treated with KA (150 μM) alone or with various sesamin concentrations (1-50 μM) for 24 h. KA-induced nitrite production was dose-dependently decreased the treatment with sesamin.

Caspase-3 activation

Apoptotic signaling pathways were investigated in KA-treated PC12 cells and BV-2 cells. The results showed that KA increased Caspase-3 activation but sesamin reduced the Caspase-3 expression dose-dependently in both cells (Figure 6 and data not shown).
Figure 6
Figure 6

Effect of sesamin on MAP kinases, RhoA and COX-2 activation in PC12 cells and BV-2 cells under KA stress. The effect of sesamin (1-50 μM) on KA-activated cell signaling pathways was determined by Western blotting under KA stress, (A) PC12 cells for 10-min and 60-min and (B) BV-2 cells for 120 min. Sesamin effectively reduced the activation of COX-2, ERK, p38 MAP kinases. * P < 0.01 as compared to the KA control. CK: normal control.

COX-2 and MAPK activation

Seizures, inflammation and apoptosis in neuronal cells are known to be initiated with several signaling pathways such as MAPKs and Rho kinases [19–21]. Therefore, the KA induced the activation of signaling pathways were studied in PC12 cells and BV-2 cells for MAP kinases (JNK, ERK, p38), RhoA, and COX-2 (Figure 6). We evaluated the effect of sesamin on KA-induced pathways in PC12 cells at 10, 30, and 60 min and in BV-2 cells 30, 60, 120 min by Western blot. Western blot analysis revealed that sesamin (50 μM) significantly reduced ERK1/2, p38 MAPKs and COX-2 expression in both cells and RhoA expression in BV-2 cells as compared to KA controls.

PGE2production

We further evaluated whether the KA-induced COX-2 change would affect PGE2 production. The result showed that sesamin reduced the PGE2 production in both KA-induced PC12 cells and BV-2 cells as predicted (Figure 7).
Figure 7
Figure 7

Effect of sesamin on PGE 2 production in PC12 cells and BV-2 cells. Sesamin dose-dependently reduced KA-induced PGE2 production in (A) PC12 cells and (B) BV-2 cells. PGE2 concentration was determined by ELISA (R&D) assay. * P < 0.01 as compared to the KA control.

Discussion

The present result showed that sesamin protected animals from KA-induced brain injury. MDA and mortality were significantly reduced as compared with the non-treated one. The decreased mortality in the sesamin-treated animals could also be confirmed by the sesamin effect in vitro that showed a decreased LDH release and Caspase-3 activation and increased cell viability in KA-stimulated PC12 cells.

The neuroprotective effect of sesamin on KA-induced injury was mainly due to its antioxidant effect on reducing of MDA, the product of lipid peroxidation both in vivo and in vitro. The antioxidant effect on reducing of MDA could be attributed to the increased plasma α-tocopherol level from the supplementation with sesamin extract (Table 1). This is consistent with a study that reports consumption of sesame seed powder over five weeks increases plasma α-tocopherol levels in healthy human volunteers [32]. KA administration is associated with a depletion of ATP levels and accumulation of [Ca2+ ]i. PC12 cells treated with KA for 24 h reduced cell viability dose-dependently by MTT assay. This was not caused by changes in pH or osmotic pressure because the inert mannitol at the concentration of 150 mM, did not affect cell viability (data not shown). The increase in [Ca2+ ]i may trigger Ca2+ -activated free radicals formation [33]. Sesamin decreased ROS and calcium release from KA-treated PC12 cells and BV-2 cells. This agrees with the earlier reports that antioxidants can protect brain from KA-induced calcium ions and ROS release [24–26]. It is also consistent with the sesamin antioxidant effect that protects hypoxia-or H2 O2 -induced PC12 cell injury [22]. A study with defatted sesame seeds extract (30, 100 and 300 mg/kg) given twice orally at 0 h and 2 h after onset of ischemia shows the reduction of brain infarct volume dose-dependently and improves sensory-motor function [34]. Thus, suppression of KA-induced ROS and Ca2+ release by sesamin was consistent with these notions. Since seizure can be triggered by the KA-induced calcium ions release, the decreased severity of seizure behavior could be partially attributed to the sesamin antioxidative effect, although it was not statistically significant due to the small sample sizes

Since microglial activation as one mechanism by which early-life seizures contribute to increased vulnerability to neurologic insults in adulthood, therapies that regulate of proinflammatory cytokines would be beneficial [35]. Present results showed that NO. production in KA-stimulated BV-2 cells was dose-dependently reduced by sesamin and PGE2 production from both cells under KA stress was also significantly reduced. This agrees with other studies that sesamin protects PC12 cells from MPP+ -induced cellular death by increasing the SOD activity and inducible nitric oxide synthase protein (iNOS) expression and microglia from reducing interleukin-6 (IL-6) mRNA levels [23]. We have reported previously that sesamin or sesamolin inhibits NO, iNOS, tumor necrosis factor-α and IL-6 production in LPS-stimulated BV-2 microglia [27]. In addition, sesamin and sesamolin also reduced LPS-activated cytokine, p38 MAPK and NF-κB activations [28].

The role of COX-2 mRNA and protein in KA-induced brain injury has been reported [36–38]. The KA-induced COX-2 expression parallels the appearance of neuronal apoptotic features [36] and involves with free radicals formation [39]. Several protease families are implicated in apoptosis, the most prominent being caspases [40]. We found that KA could affect the Caspase-3 activation in PC12 cells and BV-2 cells and sesamin could reduce both Caspase-3 expression. Since KA could induce the activation of MAP kinases (JNK, ERK, p38), RhoA and COX-2 in PC12 cells, we found that sesamin suppressed KA-induced COX-2, ERK, and p38 MAPK in PC12 cells and BV-2 cells. Our result is similar to a study of tea extract (TF3) treatment that shows TF3 reduces the gene and protein expression of COX-2 and iNOS, and NF-κB activation from cerebral ischemia-reperfusion [41]. However, KA-induced RhoA pathway in BV-2 cells but not PC12 cells was reduced by sesamin.

Our data also showed that sesamin extract had the tendency to decrease the severity of seizure behavior. A recent study indicated the lack of effectiveness of antioxidants in the kainic acid SE model [42]. However, antioxidants had significant anticonvulsant activity against pilocarpine. This discrepancy could be explained by the fact that KA is a glutamate receptor agonist while pilocarpine is a muscarinic agonist [43]. Because of the small number of animals in our study, the ameliorating effect of sesamin extract on behavioral severity was not statistically significant. Further studies are needed to confirm whether sesamin has direct effects on the seizure behavior and the related molecular mechanism in this issue. The present results are consistent with previous reports that antioxidants such as resveratrol, vitamin-E, melatonin, and lipoic acids are also protective against various animal models of SE in terms of the oxidative stress or convulsions [44–51]. Particularly, resveratrol protects against KA-induced neuronal damage [7, 10, 14, 49]. However, in the present study the concentrations of sesamin likely to be achieved in vivo were too low to act as chain-breaking antioxidants. Only higher dose (30 mg/kg) of sesamin supplementation significantly increased plasma α-tocopherol level and reduced the TBARS level as compared with the vehicle control rats. It is more likely that sesamin acts as a pharmacological antioxidant by blocking enzymes or pathways of neuroinflammation that would produce ROS/RNS.

Stopping the seizure activity earlier is the best way to prevent SE-induced free radicals and neuronal damage. However, clinical experience shows that SE can be refractory to the commonly used medications. Therefore, intervention by antioxidants can be a potential beneficial approach in the treatment of SE.

Conclusion

Sesamin ameliorates oxidative stress in KA-induced status epilepticus and warrants further study for the molecular mechanism.

Notes

List of abbreviations

(COX-2): 

Cyclooxygenase-2

(DCF): 

dichlorofluorescein

(DMEM): 

Dulbecco's modified Eagle's medium

(FBS): 

fetal bovine serum

(H2 DCF-DA): 

2',7'-dichlorodihydrofluorescein diacetate

(HBSS): 

Hank's balanced salt solution

(IL-6): 

interleukin-6

(iNOS): 

Inducible-nitric oxide synthase

(KA): 

Kainic acid

(LDH): 

Lactate dehydrogenase

(LPO): 

lipid peroxidation

(LPS): 

Lipopolysaccharide

(MDA): 

Malondialdehyde

(MAPKs): 

Mitogen-activated protein kinases

(MPP+): 

1-methyl-4-phenyl-pyridine

(MTT): 

3-(4,5-dimethyl-thiazol-2-yl)-2,5-diphenyl tetrazolium bromide

(NADH): 

nicotinamide adenine dinucleotide

(NF-κB): 

Nuclear factor-κB

(NO): 

Nitric oxide

(PBS): 

Phosphate-buffered saline

(PC12 cells): 

Pheochromacytoma

(PGE2): 

Prostaglandin E2

(ROS): 

Reactive oxygen species

(SE): 

Status epilepticus

(SOD): 

Superoxide dismutase

(TBARS): 

thiobarbituric acid reacting substances

Declarations

Acknowledgements

This work was supported by grants from the National Science Council, ROC (NSC 93-2314-B-075A-021, NSC 94-2314-B-075A-006) and Taichung Veterans General Hospital (TCVGH-943401A, TCVGH-983401A).

Authors’ Affiliations

(1)
Division of Neurology, Taichung Veterans General Hospital, Taichung, Taiwan
(2)
Graduate Institute of Biomedicine and Biomedical Technology, National Chi Nan University, Nantou, Taiwan
(3)
Department of Biotechnology, Yuanpei University, Hsinchu, Taiwan
(4)
Department of Physical Education Office, Yuanpei University, Hsinchu, Taiwan
(5)
Department of Medical Research, Taichung Veterans General Hospital, Taichung, Taiwan

References

  1. Wasterlain CG, Fujikawa DG, Penix L, Sankar R: Pathophysiological mechanisms of brain damage from status epilepticus. Epilepsia. 1993, 34: S37-S53. 10.1111/j.1528-1157.1993.tb05905.x.View ArticlePubMedGoogle Scholar
  2. Millikan D, Rice B, Silbergleit R: Emergency treatment of status epilepticus: current thinking. Emerg Med Clin North Am. 2009, 27: 101-113. 10.1016/j.emc.2008.12.001.View ArticlePubMedGoogle Scholar
  3. Rocca WA, Sharbrough FW, Hauser WA, Annegers JF, Schoenberg BS: Risk factors for complex partial seizures: a population-based case-control study. Ann Neurol. 1987, 21: 22-31. 10.1002/ana.410210106.View ArticlePubMedGoogle Scholar
  4. Lee B, Cao R, Choi YS, Cho HY, Rhee AD, Hah CK, Hoyt KR, Obrietan K: The CREB/CRE transcriptional pathway: protection against oxidative stress-mediated neuronal cell death. J Neurochem. 2009, 108: 1251-1265. 10.1111/j.1471-4159.2008.05864.x.PubMed CentralView ArticlePubMedGoogle Scholar
  5. Penner MR, Pinaud R, Robertson HA: Rapid kindling of the hippocampus protects against neural damage resulting from status epilepticus. Neuroreport. 2001, 12: 453-457. 10.1097/00001756-200103050-00007.View ArticlePubMedGoogle Scholar
  6. Turski L, Ikonomidou C, Turski WA, Bortolotto ZA, Cavalheiro EA: Review: cholinergic mechanisms and epileptogenesis. The seizures induced by pilocarpine: a novel experimental model of intractable epilepsy. Synapse. 1989, 3: 154-171. 10.1002/syn.890030207.View ArticlePubMedGoogle Scholar
  7. Wang Q, Yu S, Simonyi A, Rottinghaus G, Sun GY, Sun AY: Resveratrol protects against neurotoxicity induced by kainic acid. Neurochem Res. 2004, 29: 2105-2112. 10.1007/s11064-004-6883-z.View ArticlePubMedGoogle Scholar
  8. Muller-Schwarze AB, Tandon P, Liu Z, Yang Y, Holmes GL, Stafstrom CE: Ketogenic diet reduces spontaneous seizures and mossy fiber sprouting in the kainic acid model. Neuroreport. 1999, 10: 1517-1522. 10.1097/00001756-199905140-00023.View ArticlePubMedGoogle Scholar
  9. Wasterlain CG, Shirasaka Y, Mazarati AM, Spigelman I: Chronic epilepsy with damage restricted to the hippocampus: possible mechanisms. Epilepsy Res. 1996, 26: 255-265. 10.1016/S0920-1211(96)00058-7.View ArticlePubMedGoogle Scholar
  10. Gupta YK, Briyal S, Chaudhary G: Protective effect of trans-resveratrol gainst kainic acid-induced seizures and oxidative stress in rats. Pharmacol Biochem Behav. 2002, 71: 245-249. 10.1016/S0091-3057(01)00663-3.View ArticlePubMedGoogle Scholar
  11. Miyamoto R, Shimakawa S, Suzuki S, Ogihara T, Tamai H: Edaravone prevents kainic acid-induced neuronal death. Brain Res. 2008, 1209: 85-91.View ArticlePubMedGoogle Scholar
  12. Freitas RM, Sousa FC, Vasconcelos SM, Viana GS, Fonteles MM: Pilocarpine-induced status epilepticus in rats: lipid peroxidation level, nitrite formation, GABAergic and glutamatergic receptor alterations in the hippocampus, striatum and frontal cortex. Pharmacol Biochem Behav. 2004, 78: 327-332. 10.1016/j.pbb.2004.04.004.View ArticlePubMedGoogle Scholar
  13. Bashkatova V, Narkevich V, Vitskova G, Vanin A: The influence of anticonvulsant and antioxidant drugs on nitric oxide level and lipid peroxidation in the rat brain during penthylenetetrazole-induced epileptiform model seizures. Prog Neuropsychopharmacol Biol Psychiatry. 2003, 27: 487-492. 10.1016/S0278-5846(03)00037-X.View ArticlePubMedGoogle Scholar
  14. Meyerhoff JL, Lee JK, Rittase BW, Tsang AY, Yourick DL: Lipoic acid pretreatment attenuates ferric chloride-induced seizures in the rat. Brain Res. 2004, 1016: 139-144. 10.1016/j.brainres.2004.03.019.View ArticlePubMedGoogle Scholar
  15. Sun AY, Cheng Y, Bu Q, Oldfield F: The biochemical mechanism of the excitotoxicity of kainic acid. Mol Chem Neuropathol. 1992, 17: 51-63. 10.1007/BF03159981.View ArticlePubMedGoogle Scholar
  16. Bruce AJ, Baudry M: Oxygen free radicals in rat limbic structures after kainate-induced seizures. Free Radical Biol Med. 1995, 18: 993-1002. 10.1016/0891-5849(94)00218-9.View ArticleGoogle Scholar
  17. D'Antuono M, Benini R, Biagini G, D'Arcangelo G, Barbarosie M, Tancredi V, Avoli M: Limbic network interactions leading to hyperexcitability in a model of temporal lobe epilepsy. J Neurophysiol. 2002, 87: 634-639.PubMedGoogle Scholar
  18. Arispe N, Pollard HB, Rojas E: β-Amyloid Ca2+ -channel hypothesis for neuronal death in Alzheimer disease. Mol Cell Biochem. 1994, 140: 119-125. 10.1007/BF00926750.View ArticlePubMedGoogle Scholar
  19. Goodenough S, Davidson M, Chen M, Beckmann A, Pujic Z, Otsuki M, Matsumoto I: Immediate early gene expression and delayed cell death in limbic areas of the rat brain after kainic acid treatment and recovery in the cold. Exp Neurol. 1997, 145: 451-461. 10.1006/exnr.1997.6471.View ArticlePubMedGoogle Scholar
  20. Dubreuil CI, Marklund N, Deschamps K, McIntosh TK, McKerracher L: Activation of Rho after traumatic brain injury and seizure in rats. Exp Neurol. 2006, 198: 361-369. 10.1016/j.expneurol.2005.12.002.View ArticlePubMedGoogle Scholar
  21. Matagne V, Lebrethon MC, Gérard A, Bourguignon JP: Kainate/estrogen receptor involvement in rapid estradiol effects in vitro and intracellular signaling pathways. Endocrinology. 2005, 146: 2313-2323. 10.1210/en.2004-1265.View ArticlePubMedGoogle Scholar
  22. Hou RC, Chen HL, Tzen JT, Jeng KC: Effect of sesame antioxidants on LPS-induced NO production by BV2 microglial cells. Neuroreport. 2003, 14: 1815-1819. 10.1097/00001756-200310060-00011.View ArticlePubMedGoogle Scholar
  23. Lahaie-Collins V, Bournival J, Plouffe M, Carange J, Martinoli MG: Sesamin modulates tyrosine hydroxylase, superoxide dismutase, catalase, inducible NO synthase and interleukin-6 expression in dopaminergic cells under MPP-induced oxidative stress. Oxid Med Cell Longev. 2008, 1: 54-62. 10.4161/oxim.1.1.6958.PubMed CentralView ArticlePubMedGoogle Scholar
  24. Ma CJ, Kim SR, Kim J, Kim YC: Meso-dihydroguaiaretic acid and licarin A of Machilus thunbergii protect against glutamate-induced toxicity in primary cultures of a rat cortical cells. Br J Pharmacol. 2005, 146: 752-759. 10.1038/sj.bjp.0706380.PubMed CentralView ArticlePubMedGoogle Scholar
  25. Kanada A, Nishimura Y, Yamaguchi JY, Kobayashi M, Mishima K, Horimoto K, Kanemaru K, Oyama Y: Extract of Ginkgo biloba leaves attenuates kainate-induced increase in intracellular Ca2+ concentration of rat cerebellar granule neurons. Biol Pharm Bull. 2005, 28: 934-936. 10.1248/bpb.28.934.View ArticlePubMedGoogle Scholar
  26. Fukumoto LR, Mazza G: Assessing antioxidant and prooxidant activities and phenolic compounds. J Agric Food Chem. 2000, 48: 3597-3604. 10.1021/jf000220w.View ArticlePubMedGoogle Scholar
  27. Hou RC, Huang HM, Tzen JT, Jeng KC: Protective effects of sesamin and sesamolin on hypoxic neuronal and PC12 cells. J Neurosci Res. 2003, 74: 123-133. 10.1002/jnr.10749.View ArticlePubMedGoogle Scholar
  28. Jeng KC, Hou RC, Wang JC, Ping LI: Sesamin inhibits lipopolysaccharide-induced cytokine production by suppression of p38 mitogen-activated protein kinase and nuclear factor-kappaB. Immunol Lett. 2005, 97: 101-106. 10.1016/j.imlet.2004.10.004.View ArticlePubMedGoogle Scholar
  29. Ohkawa H, Ohishi N, Yagi K: Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem. 1979, 95: 351-358. 10.1016/0003-2697(79)90738-3.View ArticlePubMedGoogle Scholar
  30. Racine RJ: Modification of seizure activity by electrical stimulation. II. Motor seizure. Electroencephalogr Clin Neurophysiol. 1972, 32: 281-294. 10.1016/0013-4694(72)90177-0.View ArticlePubMedGoogle Scholar
  31. Handforth A, Ackermann RF: Functional 14 C 2-deoxyglucose mapping of progressive states of status epilepticus induced by amygdala stimulation in rat. Brain Res. 1988, 460: 94-102. 10.1016/0006-8993(88)90433-7.View ArticlePubMedGoogle Scholar
  32. Wu WH, Kang YP, Wang NH, Jou HJ, Wang TA: Sesame ingestion affects sex hormones, antioxidant status, and blood lipids in postmenopausal women. J Nutr. 2006, 136: 1270-1275.PubMedGoogle Scholar
  33. Dykens JA, Stern A, Trenkner E: Mechanisms of kainate toxicity to cerebellar neurons in vitro is analogous to reperfusion tissue injury. J Neurochem. 1987, 49: 1222-1228. 10.1111/j.1471-4159.1987.tb10014.x.View ArticlePubMedGoogle Scholar
  34. Jamarkattel-Pandit N, Pandit NR, Kim MY, Park SH, Kim KS, Choi H, Kim H, Bu Y: Neuroprotective effect of defatted sesame seeds extract against in vitro and in vivo ischemic neuronal damage. Planta Med. 2010, 76: 20-26. 10.1055/s-0029-1185903.View ArticlePubMedGoogle Scholar
  35. Somera-Molina KC, Nair S, Van Eldik LJ, Watterson DM, Wainwright MS: Enhanced microglial activation and proinflammatory cytokine upregulation are linked to increased susceptibility to seizures and neurologic injury in a 'two-hit' seizure model. Brain Res. 2009, 1282: 162-172.PubMed CentralView ArticlePubMedGoogle Scholar
  36. Hashimoto K, Watanabe K, Nishimura T, Iyo M, Shirayama Y, Minabe Y: Behavioral changes and expression of heat shock protein HSP-70 mRNA, brain-derived neurotrophic factor mRNA, and cyclooxygenase-2 mRNA in rat brain following seizures induced by systemic administration of kainic acid. Brain Res. 1998, 804: 212-223. 10.1016/S0006-8993(98)00708-2.View ArticlePubMedGoogle Scholar
  37. Sandhya TL, Ong WY, Horrocks LA, Farooqui AA: A light and electron microscopic study of cytoplasmic phospholipase A2 and cyclooxygenase-2 in the hippocampus after kainite lesions. Brain Res. 1998, 788: 223-231. 10.1016/S0006-8993(97)01552-7.View ArticlePubMedGoogle Scholar
  38. Sanz O, Estrada A, Ferrer I, Planas AM: Differential cellular distribution and dynamics of HSP70, cyclooxygenase-2, and c-Fos in the rat brain after transient focal ischemia or kainic acid. Neurosci. 1997, 80: 221-232. 10.1016/S0306-4522(97)00089-4.View ArticleGoogle Scholar
  39. Candelario-Jalil E, Ajamieh HH, Sam S, Martinez G, Leon OS: Nimesulide limits kainate-induced oxidative damage in the rat hippocampus. Eur J Pharmacol. 2000, 390: 295-298. 10.1016/S0014-2999(99)00908-5.View ArticlePubMedGoogle Scholar
  40. Sarker KP, Nakata M, Kitajima I, Nakajima T, Maruyama I: Inhibition of caspase-3 activation by SB 203580, p38 mitogen-activated protein kinase inhibitor in nitric oxide-induced apoptosis of PC-12 cells. J Mol Neurosci. 15: 243-250.Google Scholar
  41. Cai C, Li J, Wu Q, Min C, Ouyang M, Zheng S, Ma W, Lin F: Modulation of the oxidative stress and nuclear factor kappaB activation by theaflavin 3,3'-gallate in the rats exposed to cerebral ischemia-reperfusion. Folia Biol. 2007, 53: 164-172.Google Scholar
  42. Xu K, Janet L, Stringer JL: Antioxidants and free radical scavengers do not consistently delay seizure onset in animal models of acute seizures. Epilepsy & Behavior. 2008, 13: 77-82. 10.1016/j.yebeh.2008.03.002.View ArticleGoogle Scholar
  43. Turski L, Ikonomidou C, Turski WA, Bortolotto ZA, Cavalheiro EA: Cholinergic mechanisms and epileptogenesis. The seizures induced by pilocarpine: a novel experimental model of intractable epilepsy. Synapse. 1989, 3: 154-171. 10.1002/syn.890030207.View ArticlePubMedGoogle Scholar
  44. Ayyildiz M, Yildirim M, Agar E: The effects of vitamin E on penicillin-induced epileptiform activity in rats. Exp Brain Res. 2006, 174: 109-113. 10.1007/s00221-006-0425-7.View ArticlePubMedGoogle Scholar
  45. Milatovic D, Gupta RC, Dettbarn WD: Involvement of nitric oxide in kainic acid-induced excitotoxicity in rat brain. Brain Res. 2002, 957: 330-337. 10.1016/S0006-8993(02)03669-7.View ArticlePubMedGoogle Scholar
  46. Tome AR, Feng D, Freitas RM: The effects of alpha-tocopherol on hippocampal oxidative stress prior to in pilocarpine-induced seizures. Neurochem Res. 2010, 35: 580-587. 10.1007/s11064-009-0102-x.View ArticlePubMedGoogle Scholar
  47. Champney TH, Champney JA: Novel anticonvulsant action of chronic melatonin in gerbils. Neuroreport. 1992, 3: 1152-1154. 10.1097/00001756-199212000-00031.View ArticlePubMedGoogle Scholar
  48. Yamamoto HA, Mohanan PV: Ganglioside GT1B and melatonin inhibit brain mitochondrial DNA damage and seizures induced by kainic acid in mice. Brain Res. 2003, 964: 100-106. 10.1016/S0006-8993(02)04083-0.View ArticlePubMedGoogle Scholar
  49. Wu Z, Xu Q, Zhang L, Kong D, Ma R, Wang L: Protective effect of resveratrol against kainate-induced temporal lobe epilepsy in rats. Neurochem Res. 2009, 34: 1393-1400. 10.1007/s11064-009-9920-0.View ArticlePubMedGoogle Scholar
  50. Shin EJ, Jeong JH, Kim AY, Koh YH, Nah SY, Kim WK, Ko KH, Kim HJ, Wie MB, Kwon YS, Yoneda Y, Kim HC: Protection against kainate neurotoxicity by ginsenosides: attenuation of convulsive behavior, mitochondrial dysfunction, and oxidative stress. J Neurosci Res. 2009, 87: 710-722. 10.1002/jnr.21880.View ArticlePubMedGoogle Scholar
  51. Miyamoto R, Shimakawa S, Suzuki S, Ogihara T, Tamai H: Edaravone prevents kainic acid-induced neuronal death. Brain Res. 2008, 1209: 85-91.View ArticlePubMedGoogle Scholar

Copyright

© Hsieh et al; licensee BioMed Central Ltd. 2011

This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Advertisement

Journal of Neuroinflammation

ISSN: 1742-2094